Orthovita, Inc. (NASDAQ:VITA.DL)

CAPS Rating: No stars

A spine and orthopedic biosurgery company which develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of fractures and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets

Recs

0
Player Avatar PhillyDan (84.49) Submitted: 6/11/2009 12:59:46 AM : Outperform Start Price: $5.74 VITA.DL Score: -47.73

With aging baby boomers, Orthovita's unique medical implant devices will become more of a fixture to repair bone fractures for bone compression injuries. In addition, their Vitagel and Vitasure products will be employed widely in surgeries to help stop bleeding and increase healing time.

Featured Broker Partners


Advertisement